Issue Navigation
-
Editorial
-
52-54
Challenges in the screening and treatment of latent multidrug-resistant tuberculosis infection
Deng GF, Zhang PZ, Lu HZ
Drug Discov Ther. 2022; 16(2):52-54.
DOI: 10.5582/ddt.2022.01029
-
55-62
Basi-Chipalu S, Sthapit P, Dhital S
Drug Discov Ther. 2022; 16(2):55-62.
DOI: 10.5582/ddt.2021.01087
-
63-71
Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain
Román Ivorra JA, Llevat N, Montoro M
Drug Discov Ther. 2022; 16(2):63-71.
DOI: 10.5582/ddt.2022.01028
-
72-77
Physicochemical properties and detergency of special electrolyticreduction ion water
Okajima M, Okajima Y, Wada Y, Shimokawa K, Ishii F
Drug Discov Ther. 2022; 16(2):72-77.
DOI: 10.5582/ddt.2022.01027
-
78-84
Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence
Mori Y, Tanaka M, Kozai H, Hotta K, Aoyama Y, Shigeno Y, Aoike M, Kawamura H, Tsurudome M, Ito M
Drug Discov Ther. 2022; 16(2):78-84.
DOI: 10.5582/ddt.2022.01022
-
85-92
Dating the origin and dispersal of global hepatitis B virus genotype C in humans
Li T, Chen H, Sun L, Liu J
Drug Discov Ther. 2022; 16(2):85-92.
DOI: 10.5582/ddt.2022.01030
-
93-95
Sato Y, Kuwana R, Kazama I
Drug Discov Ther. 2022; 16(2):93-95.
DOI: 10.5582/ddt.2022.01031
-
96-98
Zhang PZ, Tan J, Lin Y, Zhang HL, Deng GF, Chen XY
Drug Discov Ther. 2022; 16(2):96-98.
DOI: 10.5582/ddt.2022.01024
-
99-101
Yang M, Zhan SL, Fu L, Wang YX, Zhang PZ, Deng GF
Drug Discov Ther. 2022; 16(2):99-101.
DOI: 10.5582/ddt.2022.01025
-
102-104
Arora U, Garg P, Raut SK, Vibha D, Baitha U, Kumar A, Jorwal P, Soneja M, Biswas A
Drug Discov Ther. 2022; 16(2):102-104.
DOI: 10.5582/ddt.2021.01015